POD24 Predicts Poor Prognosis in Follicular Lymphoma

Disease progression within 24 months of frontline chemoimmunotherapy (POD24) was highly predictive of poor prognosis in patients with follicular lymphoma (FL).

Validation of POD24 as a robust early clinical end point of poor ...

... (POD24), have poor outcomes. We performed a pooled analysis of 13 ... Lymphoma, Follicular* / diagnosis; Lymphoma, Follicular* / drug ...

Prognostic value of POD24 validation in follicular lymphoma patients ...

The relapse of follicular lymphoma (FL) within 24 months (POD24) of chemoimmunotherapy has been associated with poor survival. We analyzed a pooled dataset ...

Validation of POD24 as a robust early clinical end point of poor ...

Patients with follicular lymphoma (FL) who progress within 24 months of front-line therapy (POD24) have poor outcomes, but clinical factors ...

Progression of disease within 24 months (POD24) in follicular ...

... POD24 have poorer outcomes [8, 13, 15]. ... Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on ...

Effect of POD24 on the prognosis of follicular and other indolent B ...

Subsequent studies have further confirmed the strong association between POD24 and poor prognosis in patients treated with various rituximab- ...

Predicting early progression in follicular lymphoma - Liu

POD24 was also significantly associated with poor survival in the comparison with patients who had progression of disease after 24 months. In a validation ...

Early Disease Progression Predicts Poorer Survival in Patients with ...

Early Disease Progression Predicts Poorer Survival in Patients with Follicular Lymphoma (FL) in the GALLIUM Study ... (POD24) predicted poor ...

Survival by First-line Treatment Type and Timing of Progression

... treatment within 2 years of diagnosis (POD24) have a particularly bad prognosis. ... Validation of POD24 as a robust early clinical end point of poor survival in ...

Progression of Disease Within 24 Months in Follicular Lymphoma Is ...

POD24 has predicted overall survival of 26% to 50% by 5 years. A ... POD24 as an early clinical end point of poor survival in FL. A ...

Progression of disease within 24 months (POD24) in multiple ...

POD24 signifies poor prognosis across various diseases, including follicular lymphoma. This concept has extended to other lymphomas ...

Association of early disease progression and very poor survival in ...

Early disease progression in patients with follicular lymphoma was associated with poor prognosis, with mortality risk higher after earlier progression.

Impact of transformation on the survival of patients diagnosed with ...

... unfavorable event predicting poor prognosis in patients with follicular lymphoma (FL). ... worst survival outcome regardless of POD24. Conclusions ...

How I treat early-relapsing follicular lymphoma - ScienceDirect

Early disease progression predicts poorer survival ... Validation of POD24 as a robust early clinical endpoint of poor survival in follicular ...

The prognostic index PRIMA-PI combined with Ki67 as a better ...

BackgroundProgression of disease within 24 months (POD24) is a risk factor for poor survival in follicular lymphoma (FL), ...

Early Relapse in First-Line Follicular Lymphoma: A Review of the ...

HT is associated with very poor prognosis; in the GALLIUM trial analysis, with a median follow-up of 57.3 months, of the POD24 patients, 51.6% ...

Predicting and Analyzing Response in Follicular Lymphoma - OncLive

We confirmed the CT-based POD24 or PFS24 is still prognostically significant, predicts a worse outcome. But if you use a PET scan, this ...

Podcast: Intratumoral Immune Infiltration in Follicular Lymphoma

Moreover, it confirmed POD24 as an early clinical endpoint of poor survival in follicular lymphoma that should be utilized to identify patients ...

Decreased expression of T‐cell‐associated immune markers ...

... predicts poor prognosis in patients with follicular lymphoma. Shinya ... predicting clinical outcomes including POD24 in RB-treated FL patients.

Paper: The FLIPI24 Prognostic Model Identifies Poor Outcomes in ...

1657 The FLIPI24 Prognostic Model Identifies Poor Outcomes in Non-Immunochemotherapy Treated Patients with Follicular Lymphoma. Program: Oral ...